Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment

논문상세정보
' Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • anticonvulsants
  • developmental disabilities
  • epilepsy
  • intellectual disability
  • vitamin d
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,107 0

0.0%

' Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment' 의 참고문헌

  • 지적 장애아의 진단과 재활
    권정이 대한의사협회지 52 (6) : 601 ~ 610 [2009]
  • 지적 장애아의 진단과 재활
    권정이 대한의사협회지 52 6 601-610 [2009]
  • Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine
    Mintzer S Epilepsia 47 : 510 ~ 515 [2006]
  • Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine
    Mintzer S Epilepsia 47 510-515 [2006]
  • Vitamin D deficiency in children and its management: review of current knowledge and recommendations
    Misra M Pediatrics 122 : 398 ~ 417 [2008]
  • Vitamin D deficiency in children and its management: review of current knowledge and recommendations
    Misra M Pediatrics 122 398-417 [2008]
  • Vitamin D and people with intellectual disability
    Vanlint S Aust Fam Physician 37 : 348 ~ 351 [2008]
  • Vitamin D and people with intellectual disability
    Vanlint S Aust Fam Physician 37 348-351 [2008]
  • Vitamin D and bone health among children with epilepsy
    Shellhaas RA Pediatr Neurol 42 : 385 ~ 393 [2010]
  • Vitamin D and bone health among children with epilepsy
    Shellhaas RA Pediatr Neurol 42 385-393 [2010]
  • The decline in vitamin D status with age
    Baker MR Age Ageing 9 : 249 ~ 252 [1980]
  • The decline in vitamin D status with age
    Baker MR Age Ageing 9 249-252 [1980]
  • Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004
    Kumar J Pediatrics 124 : e362 ~ e370 [2009]
  • Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004
    Kumar J Pediatrics 124 e362-e370 [2009]
  • Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy
    Guo CY Epilepsia 42 : 1141 ~ 1147 [2001]
  • Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy
    Guo CY Epilepsia 42 1141-1147 [2001]
  • Hypovitaminosis D among healthy children in the United States: a review of the current evidence
    Rovner AJ Arch Pediatr Adolesc Med 162 : 513 ~ 519 [2008]
  • Hypovitaminosis D among healthy children in the United States: a review of the current evidence
    Rovner AJ Arch Pediatr Adolesc Med 162 513-519 [2008]
  • Evaluation of bone turnover in epileptic children using oxcarbazepine
    Cansu A Pediatr Neurol 39 : 266 ~ 271 [2008]
  • Evaluation of bone turnover in epileptic children using oxcarbazepine
    Cansu A Pediatr Neurol 39 266-271 [2008]
  • Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
    Bischoff-Ferrari HA Am J Clin Nutr 84 : 18 ~ 28 [2006]
  • Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
    Bischoff-Ferrari HA Am J Clin Nutr 84 18-28 [2006]
  • Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy
    Nettekoven S Eur J Pediatr 167 : 1369 ~ 1377 [2008]
  • Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy
    Nettekoven S Eur J Pediatr 167 1369-1377 [2008]
  • Effect of phenytoin on bone and vitamin D metabolism
    Bell RD Ann Neurol 5 : 374 ~ 378 [1979]
  • Effect of phenytoin on bone and vitamin D metabolism
    Bell RD Ann Neurol 5 374-378 [1979]
  • Bone health in people with epilepsy: is it impaired and what are the risk factors?
    Pack A Seizure 17 : 181 ~ 186 [2008]
  • Bone health in people with epilepsy: is it impaired and what are the risk factors?
    Pack A Seizure 17 181-186 [2008]
  • Bone health in epilepsy
    Sheth RD Epilepsia 43 : 1453 ~ 1454 [2002]
  • Bone health in epilepsy
    Sheth RD Epilepsia 43 1453-1454 [2002]
  • Benefits and requirements of vitamin D for optimal health: a review
    Grant WB Altern Med Rev 10 : 94 ~ 111 [2005]
  • Benefits and requirements of vitamin D for optimal health: a review
    Grant WB Altern Med Rev 10 94-111 [2005]
  • Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group
    Kanis JA Osteoporos Int 4 : 368 ~ 381 [1994]
  • Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group
    Kanis JA Osteoporos Int 4 368-381 [1994]
  • Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications
    Pack AM CNS Drugs 15 : 633 ~ 642 [2001]
  • Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications
    Pack AM CNS Drugs 15 633-642 [2001]